The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease

Journal of Gastroenterology

Volumn 46, Issue 2, 2011, Pages 129-137

  Naganuma, Makoto ^a   Fujii, Toshimitsu ^a   Watanabe, Mamoru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Cyclosporine A; Infliximab; Refractory ulcerative colitis; Tacrolimus

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; INFLIXIMAB; MERCAPTOPURINE; METHYLPREDNISOLONE; PLACEBO; TACROLIMUS;

CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); COLON RESECTION; CREATININE BLOOD LEVEL; CROHN DISEASE; CYTAPHERESIS; DIET RESTRICTION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG PREFERENCE; DRUG SAFETY; DRUG TARGETING; DRUG WITHDRAWAL; EARLY INTERVENTION; ENTERITIS; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERPLASIA; GINGIVITIS; GRAFT REJECTION; HAIR LOSS; HIGH RISK POPULATION; HUMAN; HYPERTENSION; HYPERTRICHOSIS; INFECTION; JAPAN; KIDNEY DYSFUNCTION; NEPHROTOXICITY; NEUROTOXICITY; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; PARESTHESIA; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; REVIEW; SIDE EFFECT; TREMOR; ULCERATIVE COLITIS;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CALCINEURIN; COLITIS, ULCERATIVE; CROHN DISEASE; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; TACROLIMUS;

EID: 79954449661     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-010-0352-z     Document Type: Review

References (53)

1. SC Truelove LJ Witts 1955 Cortisone in ulcerative colitis. Final report on a therapeutic trial Br Med J 2 104 108 10.1136/bmj.2.4931.104
2. JH Baron AM Connell TG Kanaghinis JE Lennard-Jones AF Jones 1962 Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone Br Med J 2 441 443 1:STN:280:DyaF38%2Fgs1Ciug%3D%3D 10.1136/bmj.2.5302.441 13865152
3. BE Sands 2006 Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories Gut 55 437 441 1:CAS:528:DC%2BD28XjslWlsrs%3D 10.1136/gut.2005.078055 16531519
4. H Hanai F Watanabe K Takeuchi T Iida M Yamada Y Iwaoka, et al. 2003 Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study Clin Gastroenterol Hepatol 1 28 35 10.1053/jcgh.2003.50005 15017514 (Pubitemid 37254469)
5. H Hanai F Watanabe M Yamada Y Sato K Takeuchi T Iida, et al. 2004 Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis Digestion 70 36 44 1:CAS:528:DC%2BD2cXntFSgtr8%3D 10.1159/000080079 15297776 (Pubitemid 39179238)
6. M Naganuma S Funakoshi A Sakuraba H Takagi N Inoue H Ogata, et al. 2004 Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis Inflamm Bowel Dis 10 251 257 10.1097/00054725-200405000-00012 15290920 (Pubitemid 38618255)
7. K Sawada K Kusugami Y Suzuki T Bamba A Munakata T Hibi, et al. 2005 Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment Am J Gastroenterol 100 1362 1369 10.1111/j.1572-0241.2005.41089.x 15929771 (Pubitemid 40904363)
8. J Emmrich S Petermann D Nowak I Beutner P Brock R Klingel, et al. 2007 Leukocytapheresis (LCAP) in the management of chronic active ulcerative colitis-results of a randomized pilot trial Dig Dis Sci 52 2044 2053 1:CAS:528:DC%2BD2sXoslGisLs%3D 10.1007/s10620-006-9696-x 17410456 (Pubitemid 47246519)
9. BE Sands WJ Sandborn B Feagan R Löfberg T Hibi T Wang, et al. 2008 A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis Gastroenterology 135 400 409 1:CAS:528:DC%2BD1cXhtVCqsL%2FM 10.1053/j.gastro.2008.04.023 18602921
10. C Abraham JH Cho 2009 Inflammatory bowel disease New Engl J Med 361 2066 2078 1:CAS:528:DC%2BD1MXhsVequ7bE 10.1056/NEJMra0804647 19923578
11. Abbas AK, Lichtman AH. Activation of T lymphocytes. In: Malley J, editor. Cellular and molecular immunology. 5th ed. Philadelphia: Saunders; 2003.
12. PR Mangan LE Harrington DB O'Quinn WS Helms DC Bullard CO Elson, et al. 2006 Transforming growth factor-beta induces development of the T(H)17 lineage Nature 441 231 234 1:CAS:528:DC%2BD28XksVGns7k%3D 10.1038/nature04754 16648837
13. MJ McGeachy DJ Cua 2007 The link between IL-23 and Th17 cell-mediated immune pathologies Semin Immunol 19 372 376 1:CAS:528:DC%2BD1cXisVSrsLg%3D 10.1016/j.smim.2007.10.012 18319054 (Pubitemid 351274049)
14. S Lichtiger DH Present 1990 Preliminary report: cyclosporin in treatment of severe active ulcerative colitis Lancet 336 16 19 1:STN:280: DyaK3czgvFCltQ%3D%3D 10.1016/0140-6736(90)91521-B 1973211 (Pubitemid 20207870)
15. S Lichtiger DH Present A Kornbluth I Gelernt J Bauer G Galler, et al. 1994 Cyclosporine in severe ulcerative colitis refractory to steroid therapy N Engl J Med 330 1841 1845 1:STN:280:DyaK2c3lsV2ltA%3D%3D 10.1056/ NEJM199406303302601 8196726 (Pubitemid 24188135)
16. G D'Haens L Lemmens K Geboes L Vandeputte F Van Acker L Mortelmans, et al. 2001 Intravenous cyclosporin versus intravenous glucocorticosteroids as a single therapy for severe attacks of ulcerative colitis Gastroenterology 120 1323 1329 10.1053/gast.2001.23983 11313301 (Pubitemid 32322305)
17. G Van Assche G D'Haens M Noman S Vermeire M Hiele K Asnong, et al. 2003 Randomized double-blind comparison of 4 mg/kg/day versus 2 mg/kg/day intravenous cyclosporin in severe ulcerative colitis Gastroenterology 125 1025 1031 10.1016/S0016-5085(03)01214-9 14517785 (Pubitemid 37193449)
18. D Moskovitz G Van Assche B Maenhout J Arts M Ferrante S Vermeire, et al. 2006 Incidence of colectomy during long term follow up after cyclosporin-induced remission of severe ulcerative colitis Clin Gastroenterol Hepatol 4 760 765 1:CAS:528:DC%2BD28XmvVylsro%3D 10.1016/j.cgh.2006.04.001 16716758 (Pubitemid 43833506)
19. S Campbell S Travis D Jewell 2005 Ciclosporin use in acute ulcerative colitis: a long-term experience Eur J Gastroenterol Hepatol 17 79 84 1:CAS:528:DC%2BD2MXjs1WhtA%3D%3D 10.1097/00042737-200501000-00016 15647646 (Pubitemid 40128931)
20. J Arts G D'Haens M Zeegers G Van Assche M Hiele A D'Hoore, et al. 2004 Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis Inflamm Bowel Dis 10 73 78 10.1097/00054725-200403000- 00002 15168804 (Pubitemid 38332164)
21. L Message A Bourreille D Laharie A Quinton JP Galmiche H Lamouliatte, et al. 2005 Efficacy of intravenous cyclosporin in moderately severe ulcerative colitis refractory to steroids Gastroenterol Clin Biol 29 231 235 1:CAS:528:DC%2BD2MXjvFamtrg%3D 10.1016/S0399-8320(05)80754-7 15864171 (Pubitemid 40516308)
22. F Fernandez-Banares X Bertran M Esteve-Comas E Cabre M Menacho P Humbert, et al. 1996 Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis Am J Gastroenterol 91 2498 2499 1:CAS:528:DyaK2sXisVSktA%3D%3D 8946973 (Pubitemid 26406297)
23. RD Cohen R Stein SB Hanauer 1999 Intravenous cyclosporin in ulcerative colitis: a five-year experience Am J Gastroenterol 94 1587 1592 1:CAS:528:DyaK1MXktVKnu7g%3D 10.1111/j.1572-0241.1999.01149.x 10364029 (Pubitemid 29260450)
24. Kobayashi T, Naganuma M, Okamoto, Hisamatsu T, Inoue N, Ichikawa H, et al. 2010. Rapid endoscopic improvement is important for 1-year avoidance of colectomy but not for the long-term prognosis in cyclosporine A treatment for ulcerative colitis. J Gastroenterol (in press).
25. GR Lichtenstein MT Abreu R Cohen W Tremaine 2006 American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators and infliximab in inflammatory bowel disease Gastroenterology 130 940 987 1:CAS:528:DC%2BD28XjsVylt7o%3D 10.1053/j.gastro.2006.01.048 16530532 (Pubitemid 43374543)
26. M Naganuma H Ichikawa N Inoue T Kobayashi S Okamoto T Hisamatsu, et al. 2010 Novel endoscopic activity index is useful for choosing treatment in severe active ulcerative colitis patients J Gastroenterol 45 936 943 10.1007/s00535-010-0244-2 20401498
27. GV Asshue S Vermeire P Rutgeerts 2008 Treatment of severe steroid refractory ulcerative colitis World J Gastroenterol 14 5508 5511 10.3748/wjg.14.5508
28. P Rutgeerts WJ Sandborn BG Feagan, et al. 2005 Infliximab for induction and maintenance therapy for ulcerative colitis N Engl J Med 353 2462 2476 1:CAS:528:DC%2BD2MXhtlShurjE 10.1056/NEJMoa050516 16339095 (Pubitemid 41770166)
29. GR Lichtenstein MT Abreu R Cohen W Tremaine 2006 American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease Gastroenterology 130 935 939 10.1053/j.gastro.2006.01.047 16530531 (Pubitemid 43374542)
30. M Carter AJ Lobo SPL Travis 2004 Guidelines for the management of inflammatory bowel disease in adults Gut 53 Suppl V 1 16 10.1136/gut.2004.043372 (Pubitemid 39120096)
31. G Järnerot E Hertervig I Friis-liby L Blomquist P Karlén C Grännö, et al. 2005 Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized placebo-controlled study Gastroenterology 128 1805 1811 10.1053/j.gastro.2005.03.003 15940615 (Pubitemid 40824691)
32. Fellermann K, Tanko Z, Herrlinger KR, Witthoeft T, Homann N, Bruening A, et al. Response of refractory colitis to intravenous or oral tacrolimus (FK506). Inflamm Bowel Dis. 2002;8:317-24.
33. C Hogenauer HH Wenzl TA Hinterleitner W Petritsch 2003 Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis Aliment Pharmacol Ther 18 415 423 1:CAS:528:DC%2BD3sXnvFejsLw%3D 10.1046/j.1365-2036.2003.01662.x 12940927 (Pubitemid 37070240)
34. H Ogata T Matsui M Nakamura M Iida M Takazoe Y Suzuki, et al. 2006 A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis Gut 55 1255 1262 1:CAS:528:DC%2BD28XhtVehurnE 10.1136/gut.2005.081794 16484504 (Pubitemid 44277355)
35. DC Baumgart JK Macdonald B Feagan 2008 Tacrolimus (FK506) for induction of remission in refractory ulcerative colitis Cochrane Database Syst Rev 3 CD007216 18646177
36. C Romano D Comito A Famiani W Fries 2010 Oral tacrolimus (FK 506) in refractory paediatric ulcerative colitis Aliment Pharmacol Ther 31 676 677 1:CAS:528:DC%2BC3cXktlSmsLs%3D 10.1111/j.1365-2036.2009.04213.x 20148798
37. S Yamamoto H Nakase S Mikami S Inoue T Yoshino Y Takeda, et al. 2008 Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis Aliment Pharmacol Ther 28 589 597 1:CAS:528:DC%2BD1cXhtFWms7nL 10.1111/j.1365-2036.2008.03764.x 18549460
38. DC Baumgart JP Pintoffl A Sturm B Wiedenmann AU Dignass 2006 Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease-a long-term follow-up Am J Gastroenterol 101 1048 1056 1:CAS:528:DC%2BD28XlsFGqtLY%3D 10.1111/j.1572-0241. 2006.00524.x 16573777 (Pubitemid 43725319)
39. SC Ng N Arebi MA Kamm 2007 Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease Inflamm Bowel Dis 13 129 134 10.1002/ibd.20052 17206694 (Pubitemid 46806220)
40. A Benson T Barrett M Sparberg AL Buchman 2008 Efficacy and safety of tacrolimus in refractory ulcerative colitis and Crohn's disease: a single-center experience Inflamm Bowel Dis 14 7 12 10.1002/ibd.20263 17879277 (Pubitemid 351196862)
41. DC Baumgart B Wiedenmann AU Dignass 2003 Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease Aliment Pharmacol Ther 17 1273 1281 1:CAS:528:DC%2BD3sXltleis7k%3D 10.1046/j.1365-2036.2003.01534.x 12755840 (Pubitemid 36693728)
42. G D'Haens 2005 Infliximab for ulcerative colitis: finally some answers Gastroenterology 128 2161 2166 10.1053/j.gastro.2005.04.019 15940648 (Pubitemid 40824721)
43. KR Herrlinger DN Barthel KJ Schmidt J Büning CS Barthel J Wehkamp, et al. 2010 Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus Aliment Pharmacol Ther 31 676 677 10.1111/j.1365-2036.2009.04213.x
44. S Yamamoto H Nakase M Matsuura Y Honzawa S Masuda K Inui, et al. 2010 Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus J Gastroenterol Hepatol 25 886 891 1:CAS:528: DC%2BC3cXnvFKgur8%3D 10.1111/j.1440-1746.2009.06206.x 20546441
45. EA Maser D Deconda S Lichtiger T Ullman DH Present A Kornbluth 2008 Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis Clin Gastroenterol Hepatol 6 1112 1116 1:CAS:528:DC%2BD1cXhtlSgtL3J 10.1016/j.cgh.2008.04.035 18928936
46. SC Ng MA Kamm 2009 Therapeutic strategies for the management of ulcerative colitis Inflamm Bowel Dis 15 935 950 10.1002/ibd.20797 18985710
47. SP Travis EF Stange M Lémann T Oresland Y Chowers A Forbes, et al. 2006 European evidence based consensus on the diagnosis and management of Crohn's disease: current management Gut 55 Suppl 1 i16 i35 10.1136/gut.2005. 081950b 16481629 (Pubitemid 43268291)
48. G D'Haens F Baert G van Assche P Caenepeel P Vergauwe H Tuynman, et al. 2008 Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial Lancet 371 660 667 10.1016/S0140-6736(08)60304-9 18295023 (Pubitemid 351284485)
49. F Baert L Moortgat G Van Assche P Caenepeel P Vergauwe M De Vos, et al. 2010 Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease Gastroenterology 138 463 468 10.1053/j.gastro.2009. 09.056 19818785
50. S Lichtiger 2009 Treatment of choice for acute severe steroid-refractory ulcerative colitis is cyclosporine Inflamm Bowel Dis 15 141 142 10.1002/ibd.20363 18266232
51. A Sakuraba T Sato M Naganuma Y Morohoshi K Matsuoka N Inoue, et al. 2008 A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis J Gastroenterol 43 51 56 10.1007/s00535-007-2129-6 18297436 (Pubitemid 351324986)
52. A Sakuraba S Motoya K Watanabe M Nishishita K Kanke T Matsui, et al. 2009 An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment Am J Gastroenterol 104 2990 2995 10.1038/ajg.2009.453 19724269
53. K Fukunaga Y Yokoyama K Kamikozuru N Hida Y Ohda S Nakamura, et al. 2010 A prospective randomized double blind sham controlled trial to assess the efficacy of monthly granulocyte/monocyte adsorption apheresis as maintenance therapy for patients with steroid refractory ulcerative colitis Gut 59 A73